Verastem, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Verastem, Inc. (VSTM) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 7.06 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 7.06M shares, a 58.59% increase year-over-year.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 5.56M shares, a 74.78% decline year-over-year.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 13.39M shares, a 50.10% decline year-over-year.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 4.45M shares, a 46.97% decline year-over-year.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 12.78M shares, a 42.97% decline from fiscal 2024.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 22.41M shares, a 196.60% increase from fiscal 2023.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 7.56M shares, a 245.91% increase from fiscal 2022.
- Verastem, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 2.18M shares, a 36.78% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 5 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 29 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 41 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 7.06M shares 10-Q · filed 2026-08-06 | 7.06M shares 10-Q · filed 2026-08-06 | |||||||||
| 2026-03-31 | 5.56M shares 10-Q · filed 2026-05-07 | ||||||||||
| 2025-12-31 | 12.78M shares 10-K · filed 2026-03-04 | ||||||||||
| 2025-09-30 | 13.39M shares 10-Q · filed 2025-11-04 | 13.39M shares 10-Q · filed 2025-11-04 | |||||||||
| 2025-06-30 | 4.45M shares 10-Q · filed 2026-08-06 | 4.45M shares 10-Q · filed 2026-08-06 | |||||||||
| 2025-03-31 | 22.05M shares 10-Q · filed 2026-05-07 | ||||||||||
| 2024-12-31 | 22.41M shares 10-K · filed 2026-03-04 | ||||||||||
| 2024-09-30 | 26.83M shares 10-Q · filed 2025-11-04 | 26.83M shares 10-Q · filed 2025-11-04 | |||||||||
| 2024-06-30 | 8.40M shares 10-Q · filed 2025-08-07 | 8.40M shares 10-Q · filed 2025-08-07 | |||||||||
| 2024-03-31 | 7.63M shares 10-Q · filed 2025-05-13 | ||||||||||
| 2023-12-31 | 7.56M shares 10-K · filed 2026-03-04 | ||||||||||
| 2023-09-30 | 7.43M shares 10-Q · filed 2024-11-06 | 7.43M shares 10-Q · filed 2024-11-06 | |||||||||
| 2023-06-30 | 7.23M shares 10-Q · filed 2024-08-08 | 7.23M shares 10-Q · filed 2024-08-08 | |||||||||
| 2023-03-31 | 7.22M shares 10-Q · filed 2024-05-09 | 86.61M shares 10-Q · filed 2023-05-09 | |||||||||
| 2022-12-31 | 2.18M shares 10-K · filed 2025-03-20 | 26.22M shares 10-K · filed 2023-03-14 | |||||||||
| 2022-09-30 | 1.35M shares 10-Q · filed 2023-11-08 | 16.26M shares 10-Q · filed 2022-11-03 | 1.35M shares 10-Q · filed 2023-11-08 | 16.26M shares 10-Q · filed 2022-11-03 | |||||||
| 2022-06-30 | 1.60M shares 10-Q · filed 2023-08-08 | 19.25M shares 10-Q · filed 2022-08-08 | 1.60M shares 10-Q · filed 2023-08-08 | 19.25M shares 10-Q · filed 2022-08-08 | |||||||
| 2022-03-31 | 18.64M shares 10-Q · filed 2023-05-09 | ||||||||||
| 2021-12-31 | 1.60M shares 10-K · filed 2024-03-14 | 19.17M shares 10-K · filed 2022-03-28 | |||||||||
| 2021-09-30 | 14.77M shares 10-Q · filed 2022-11-03 | 14.77M shares 10-Q · filed 2022-11-03 | |||||||||
| 2021-06-30 | 24.14M shares 10-Q · filed 2022-08-08 | 24.14M shares 10-Q · filed 2022-08-08 | |||||||||
| 2021-03-31 | 24.06M shares 10-Q · filed 2022-05-09 | ||||||||||
| 2020-12-31 | 24.05M shares 10-K · filed 2023-03-14 | ||||||||||
| 2020-09-30 | 16.37M shares 10-Q · filed 2021-11-04 | 20.73M shares 10-Q · filed 2021-11-04 | |||||||||
| 2020-06-30 | 18.96M shares 10-Q · filed 2021-08-02 | 18.83M shares 10-Q · filed 2020-08-10 | 18.96M shares 10-Q · filed 2021-08-02 | 18.83M shares 10-Q · filed 2020-08-10 | |||||||
| 2020-03-31 | 19.90M shares 10-Q · filed 2021-05-11 | 19.77M shares 10-Q · filed 2020-05-07 | |||||||||
| 2019-12-31 | 56.91M shares 10-K · filed 2022-03-28 | 56.68M shares 10-K · filed 2020-03-11 | |||||||||
| 2019-09-30 | 38.51M shares 10-Q · filed 2020-11-09 | 38.25M shares 10-Q · filed 2019-10-30 | 38.51M shares 10-Q · filed 2020-11-09 | 38.25M shares 10-Q · filed 2019-10-30 | |||||||
| 2019-06-30 | 38.31M shares 10-Q · filed 2020-08-10 | 38.31M shares 10-Q · filed 2020-08-10 | |||||||||
| 2019-03-31 | 35.80M shares 10-Q · filed 2020-05-07 | ||||||||||
| 2018-12-31 | 12.83M shares 10-K · filed 2021-03-18 | ||||||||||
| 2018-09-30 | 13.23M shares 10-Q · filed 2019-10-30 | 13.23M shares 10-Q · filed 2019-10-30 | |||||||||
| 2018-06-30 | 11.55M shares 10-Q · filed 2019-08-01 | 11.55M shares 10-Q · filed 2019-08-01 | |||||||||
| 2018-03-31 | 10.98M shares 10-Q · filed 2019-05-09 | ||||||||||
| 2017-12-31 | 8.72M shares 10-K · filed 2020-03-11 | ||||||||||
| 2017-09-30 | 8.43M shares 10-Q · filed 2018-11-07 | 8.43M shares 10-Q · filed 2018-11-07 | |||||||||
| 2017-06-30 | 7.57M shares 10-Q · filed 2018-08-08 | 7.57M shares 10-Q · filed 2018-08-08 | |||||||||
| 2017-03-31 | 7.34M shares 10-Q · filed 2018-05-03 | ||||||||||
| 2016-12-31 | 5.99M shares 10-K · filed 2019-03-12 | ||||||||||
| 2016-09-30 | 6.02M shares 10-Q · filed 2017-11-07 | 6.02M shares 10-Q · filed 2017-11-07 | |||||||||
| 2016-06-30 | 6.83M shares 10-Q · filed 2017-08-08 | 6.83M shares 10-Q · filed 2017-08-08 | |||||||||
| 2016-03-31 | 5.62M shares 10-Q · filed 2017-05-10 | ||||||||||
| 2015-12-31 | 5.59M shares 10-K · filed 2018-03-13 | ||||||||||
| 2015-09-30 | 5.52M shares 10-Q · filed 2016-11-07 | 5.52M shares 10-Q · filed 2016-11-07 | |||||||||
| 2015-06-30 | 5.76M shares 10-Q · filed 2016-08-08 | 5.76M shares 10-Q · filed 2016-08-08 | |||||||||
| 2015-03-31 | 5.70M shares 10-Q · filed 2016-05-09 | ||||||||||
| 2014-12-31 | 4.65M shares 10-K · filed 2017-03-23 | ||||||||||
| 2013-12-31 | 3.25M shares 10-K · filed 2016-03-03 | 3.25M shares 10-K · filed 2014-03-06 | |||||||||
| 2012-12-31 | 3.07M shares 10-K · filed 2015-03-10 | 3.07M shares 10-K · filed 2013-03-26 | |||||||||
| 2011-12-31 | 13.58M shares 10-K · filed 2014-03-06 | ||||||||||
| 2010-12-31 | 3.33M shares 10-K · filed 2013-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |